|
2024
|
Invention
|
Crystals.
Provided are crystals of 2-{[3,5-bis(trifluoromethyl)phenyl]carbamoyl}-4-chlorophenyl ... |
|
2023
|
Invention
|
Methods of treating or controlling cytotoxic cerebral edema. The present invention relates to the... |
|
|
Invention
|
Methods of administering a pharmaceutically acceptable salt of 2-{[3,5-bis(trifluoromethyl)phenyl... |
|
|
Invention
|
Crystals. Provided are crystals of 2-{[3,5-bis(trifluoromethyl)phenyl]carbamoyl}-4-chlorophenyl d... |
|
|
P/S
|
Medicaments for prophylaxis, treatment, and control of diseases and disorders in humans; Pharmace... |
|
2021
|
Invention
|
Pharmaceutical composition of aquaporin inhibitor and preparation method thereof.
Provided are a... |
|
|
Invention
|
Pharmaceutical composition of aquaporin inhibitor and preparation method thereof. Provided are a ... |
|
|
Invention
|
Methods of treating or controlling cytotoxic cerebral edema consequent to an ischemic stroke. The... |
|
|
Invention
|
Prodrug salts. Provided are novel prodrug salts of selective aquaporin inhibitors, their use as p... |
|
2020
|
Invention
|
Pharmaceutical compositions and methods of making pharmaceutical compositions comprising 2-{[3,5-... |
|
2018
|
Invention
|
Pharmaceutical compositions, methods of making pharmaceutical compositions, and kits comprising 2... |
|
|
Invention
|
Methods of treating cardiac edema, neuromyelitis optica, and hyponatremia. The present invention ... |
|
2015
|
Invention
|
Novel methods.
Provided are uses of selective aquaporin inhibitors, e.g., of aquaporin-4 or aqua... |
|
|
Invention
|
Novel methods. Provided are uses of selective aquaporin inhibitors, e.g., of aquaporin-4 or aquap... |
|
|
Invention
|
Methods of treating cerebral edema. The present invention relates to the use of selective aquapor... |
|
2014
|
Invention
|
Methods of treating aquaporin-mediated conditions. The present invention relates to the use of se... |
|
|
Invention
|
Novel formulations.
Provided are novel formulations of 2-{[3,5-bis(trifluoromethyl)phenyl]carbam... |
|
|
Invention
|
Novel formulations. Provided are novel formulations of 2-{ [3,5-bis( trifluoromethyl)phenyl ]carb... |
|
|
Invention
|
Novel methods. The present invention relates to the use of selective aquaporin inhibitors, e.g., ... |
|
|
Invention
|
Novel prodrug salts. Provided are novel prodrug salts of selective aquaporin inhibitors, their us... |
|
2013
|
Invention
|
Methods of treating cerebral edema and spinal cord edema. The present invention relates to the us... |
